Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives Consensus Recommendation of “Buy” from Analysts
Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) has been assigned an average recommendation of “Buy” from the nine brokerages that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has assigned a strong buy recommendation to the […]
24 Nov 05:04 · The Cerbat Gem